The National Institutes of Health (NIH) has awarded a grant totaling $600,000 to Corgenix for a two-year study, which will focus on development of novel, recombinant-based diagnostic tests for the Ebola and Marburg viruses.
Read MoreCarolina Liquid Chemistries, GlycoMark Partner for New Diabetes Management Test Carolina Liquid Chemistries Corp will market the GlycoMark® blood test as one of a complete range of diabetes assays for the BioLis 24i benchtop chemistry analy
Read MoreAsuragen Inc has announced an agreement to develop and manufacture RNA Control Kits for Affymetrix.
Read MoreQIAGEN NV and Celera Corp announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II assay for detection of respiratory pathogens.
Read More
While molecular assays continue to be the gold standard in accuracy, point-of-care testing also moves to the fore.
Read More